News

Job Opportunity: Healthcare Innovation Project Manager

Healthcare Innovation Project Manager, based in Liverpool, UK.

2Bio Ltd. is seeking a highly motivated individual for the role of Healthcare Innovation Project Manager within our Impact Science Team, which provides innovation and commercialisation support to hospitals, universities, research organisations and private technology-based companies.

In this role you will use your expert knowledge to directly support the evaluation, development, and implementation of our clients innovative ideas. You will deliver innovation support to an established portfolio of clients, working with a high degree of independence, and you will be encouraged to help grow the portfolio in both scale and scope.

We are a successful independent consultancy based in the North West of England, and have a proven track record of delivering innovation and commercialisation support – specialising in the life sciences and healthcare sectors, and their associated technology areas, including Pharmaceuticals, Biotechnology, Medical Devices & Diagnostics, IT & Software, and Healthcare Systems.

We are a dynamic company, and value both self-starters and team players, who can take responsibility and demonstrate the flexibility needed to deliver a high-quality service to our clients, anticipating their needs whenever possible and producing exceptional levels of client satisfaction. High performance in this role will be recognised with rapid advancement and enhanced rewards.

About you

You will have a University honours degree in a science/health subject and with at least a 2.1 grade, ideally you should also have a higher degree or relevant experience in a similar role.

You will have an interest in healthcare, and an understanding of the role that innovation and technology plays in its good functioning.

With informal training provided on the job, you will quickly be capable of performing evaluations of innovations and new ways of delivering healthcare including their technical, clinical and financial merits.

You should be able to engage confidently and sympathetically with our clients innovators and ideally you will have a robust understanding of clinical practices and  associated technologies. You must be able to demonstrate excellent project management, communication and documentingskills.

You will be comfortable in a small company environment, appreciating the opportunities that it brings to demonstrate responsibility, and will understand the flexibility needed to meet the daily challenges.

To find out more:

Further particulars can be found HERE

If youd like to know more about our company, please visit the website www.impactscience.co.uk

If youre interested in applying for this job, please send your C.V., including details of relevant qualifications and experience to: info@2bio.co.uk

Advertisements

Impact Science helps to secure innovation funding from The Health Foundation

 

 

 

 

Liverpool wins three innovation awards to improve quality of health care

 Thursday 10th August

Three health projects in Liverpool have been selected by the Health Foundation, an independent health care charity, to be part of its £1.5 million innovation programme ‘Innovating for Improvement’.

The sixth round of the Innovating for Improvement programme, announced today, will support 21 health care projects across the UK, including three in Liverpool, to help improve health care delivery and/or the way people manage their own health care in the UK.

The three local health organisations which were successfully awarded the funding include NHS Liverpool Clinical Commissioning Group, Alder Hey Children’s Hospital NHS Foundation Trust and the Royal and Broadgreen University Hospitals NHS Trust.

The Innovating for Improvement programme will run for 15 months. Each of the three projects in Liverpool will receive up to £75,000 of funding to support delivery, as well as the evaluation of how the innovation improves the quality of health care.

The three Liverpool-based projects set to benefit from the funding will each focus on improving a different area of health care for patients with respiratory health needs in the city.

NHS Liverpool Clinical Commissioning Group (CCG) will use this funding to build on the success of Liverpool’s Advice on Prescription in Primary Care project, which was set up in partnership with Liverpool’s Citizens Advice Bureau (CAB) to help alleviate poverty, hardship and other common social risk factors that negatively impact on a person’s health. The project will identify new care pathways that would benefit from the scheme, and test it in respiratory services.

Dr Janet Bliss, Clinical Director for Community Services at NHS Liverpool CCG said:

“We are delighted with the news of these three Innovating for Improvement funding awards, each of which will be used to help develop cutting-edge health projects that will directly benefit local patients.

“The Advice on Prescription Project is a ground-breaking scheme which enables all Liverpool GP’s to refer their patients to CAB advisors for help on a range of social issues such as housing, homelessness, job loss and debt.

“Being part of the programme will enable us to continue to build on the successful work already being undertaken through this scheme, with the aim of reducing many of the social risk factors that can negatively impact on people’s health and wellbeing.”

The Royal Liverpool and Broadgreen University Hospitals NHS Trust will use funding from the Health Foundation to improve how heroin smokers access chronic obstructive pulmonary disease (COPD) community services across Liverpool and help reduce the time they need to spend in hospital.

A large number of heroin users in Merseyside are at risk of developing and dying from COPD, a lung disease associated with smoking that causes symptoms such as cough and breathlessness.

The innovative project, which is being led by consultant respiratory physician Dr Hassan Burhan, is engaging with patients by working in partnership with drug services, NHS Liverpool CCG, and 2Bio Ltd’s Impact Science Team who provide innovation services to the Trust and have supported the development of this project.

Dr Hassan Burhan, Consultant Respiratory Physician, Royal Liverpool and Broadgreen University Hospital NHS Trust said:

“Heroin users often don’t engage with community services, which can lead to late diagnosis of COPD and missed opportunities to slow how the disease progresses. Up to one in two heroin smokers have COPD, and one in eight admissions with exacerbations of COPD to our Trust are in patients with a history of heroin smoking.

“We are really pleased to have secured this award and look forward to implementing our ideas to improve COPD management and outcomes in this hard to reach group of patients.”

Dr Sophie Reade, Innovation and Intellectual Property Manager at 2Bio said, “This project has the potential to radically improve health outcomes for this vulnerable population simply by improving access to current COPD services within our city and so we are delighted this award has been made. We’re looking forward to working alongside the multidisciplinary team and getting started on the project.”

Alder Hey Children’s Hospital NHS Foundation Trust will use the funding to help evaluate the effectiveness of their SCORE programme, a new healthcare model that empowers children with asthma to understand their condition, self-manage it and participate in activities. The model involves an initial consultation to set goals and optimise treatments, a peer-group educational intervention, and two blocks of activity.

Dr Ian Sinha, Consultant Respiratory Paediatrician at Alder Hey Children’s Hospital said:

“We are delighted to have received this funding award for this new approach to asthma treatment, which is centered around children and communities. We hope to demonstrate that it is both clinically effective and cost-effective through the programme, and to be able to share this learning more widely.

“More than ever we need to be thinking creatively about new ways of working in health, and each of these innovative projects highlights that Liverpool is a forward thinking city with regards to new models of care.”
Sarah Henderson, Associate Director from the Health Foundation said:

“We are delighted to be supporting three fantastic projects in Liverpool to enhance care for patients in the local area, with a focus on improving respiratory services. We are keen to support innovation at the frontline across all sectors of health and care services, and I am pleased that we will be able to support these ambitious teams to develop and test their ideas over the next year.

“Our aim is to promote the effectiveness and impact of the teams’ innovations and show how they have succeeded in improving the quality of health care, with the intention of these being widely adopted across the UK.”

To find out more about the Innovating for Improvement programme, go to: http://www.health.org.uk/programmes/innovating-improvement

– ENDS-

Contact at NHS Liverpool CCG:

Anna Kettle, Communications Manager

T: 0151 295 3540

E: anna.kettle@liverpoolccg.nhs.uk

 

Contact at the Health Foundation:

Pete Stilwell, Senior External Affairs Manager

T: 020 7664 4647

E: peter.stilwell@health.org.uk

 

Notes to editors:

About the Health Foundation

The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK.

Our aim is a healthier population, supported by high quality health care that can be equitably accessed. We learn what works to make people’s lives healthier and improve the health care system. From giving grants to those working at the front line to carrying out research and policy analysis, we shine a light on how to make successful change happen.

We make links between the knowledge we gain from working with those delivering health and health care and our research and analysis. Our aspiration is to create a virtuous circle, using what we know works on the ground to inform effective policymaking and vice versa.

We believe good health and health care are key to a flourishing society. Through sharing what we learn, collaborating with others and building people’s skills and knowledge, we aim to make a difference and contribute to a healthier population.  www.health.org.uk

 

About 2Bio Limited and the Impact Science Team

2Bio Limited is a UK-based company that provides commercial services, including innovation and IP support, which is delivered through its Impact Science Team. In the UK healthcare sector, 2Bio works predominantly with NHS Trusts and has been providing regular innovation support services to the Royal since 2011 and in 2015 was commissioned by the North West Coast AHSN to create the NHS Innovation Toolkit, which is intended to broaden access to IP and innovation support for smaller or less research-intensive NHS trusts. 2Bio also works with a diverse portfolio of research-related IP and innovations, originating from our UK and international clients, and provides ‘hands on’ support for new business creation in the Life Sciences and Healthcare Industry sectors. Further information can be found at www.impactscience.co.uk or follow us on twitter @impact_science

2Bio Client CLYZ Labs Ltd is Recruiting

2Bio’s client, CLYZ Labs Ltd is recruiting into a number of positions at the moment.

CLYZ Labs Ltd is a personalised cancer chemosensitivity testing service laboratory. The company is developing a 3D cell culture system to determine the most appropriate choice of chemotherapy for cancer patients. The company is initially focused upon development and clinical validation of a chemosensitivity test for lung cancer.

CLYZ Labs Ltd is headquartered at BioHUB at Alderley Park and has a laboratory facility at The Heath, Runcorn.

CLYZ Labs Ltd is currently recruiting into the following positions:

2Bio’s Impact Science Team are working with CLYZ Labs Ltd to support establishment of partnerships and operations.

Impact Science Supports RESOLVE Health Technology Program.

resolve-story-image

2Bio’s Impact Science team is pleased to announce that it will be supporting the RESOLVE programme in Northern Portugal to develop and nurture early stage projects and start-ups in the health technology sector.

The RESOLVE Programme is designed to address the gap between health research and its commercial application, so that the outputs of the vibrant healthcare research sector in Northern Portugal can be harnessed by industry to grow the economy and improve the health outcomes for the region’s population.

The focus of this programme will be on developing the most valuable health technology opportunities by applying the RESOLVE toolbox, which includes proof of concept work, prototype validation, specialised clinical product and market development tools, and connections to end users and investors. The Impact Science Team will be involved in evaluating the opportunities and building the commercial strategies for selected RESOLVE companies and projects. More information on RESOLVE can be found on the dedicated website (http://www.resolve-health.pt).

The RESOLVE programme is being hosted by i3S in Porto, which incorporates IBMC, INEB and Ipatimup – three leading national research institutes – and it is funded by NORTE2020

The RESOLVE programme is designed to tackle specific challenges in the origin of the “Death Valley” for startups in the health sector. The RESOLVE Toolbox will be applied in a targeted manner to the needs identified in a detailed diagnosis made to the technology/team during the selection process. “Our goal is to maximise the potential of the outstanding technologies generated primarily in the northern region, and in a second stage in Portugal and abroad. We believe that having the Impact Science Team on board will help RESOLVE to push the technologies to the market.”, commented João Cortez from the RESOLVE team.

2Bio’s Director, Dr. Rhys Roberts, whose company has an international client base, commented “there is now a global demand for new ideas and products that will improve the standards of healthcare, and also make it more affordable to deliver; the RESOLVE approach to identifying and shaping commercial opportunities at an early stage should result in a much stronger offering for investors and for the growing global healthcare technology sector.

For further information please Contact:

Dr. Rhys Roberts, Director 2bio Ltd., Email: info@2bio.co.uk

Dr. João Cortez, Executive Director of the RESOLVE Program, Email: resolve@i3s.up.pt

Impact Science helps RLBUHT to win innovation award… again!

03/11/2016

health_foundation_logo

A team from the Royal Liverpool and Broadgreen University Hospitals NHS Trust have been selected by the Health Foundation, an independent health care charity, to be part of its £1.5 million innovation programme, Innovating for Improvement. This is the second major award that 2Bio’s Impact Science team has helped RLBUHT to win from The Health Foundation this year.

The fifth round of the Innovating for Improvement programme is supporting 22 health care projects in the UK with the aim of improving health care delivery and/or the way people manage their own health care by testing and developing innovative ideas and approaches and putting them into practice.

The innovative project from the alcohol services team at the Royal Liverpool University Hospital aims to implement a new nurse-led clinical pathway for patients who are vulnerable to Alcohol-Related Brain Injury (ARBI), a form of dementia.

This pathway is intended to improve the identification of patients with early signs of cognitive impairment (a symptom of ARBI), which will enable the alcohol team to select and implement the most appropriate interventions aimed at improving that patient’s cognitive function and their ability to abstain from alcohol.

The intervention will make it easier for carers, community services and GPs to understand the patient’s needs and to manage their care more appropriately, increasing the chances of improving their health and building greater understanding of the support they will need from the community to manage their condition.

Over the course of the programme the team will develop its innovative idea and approach, put it into practice and gather evidence about how the innovation improves the quality of health care.

The team will be led by Dr Paul Richardson, consultant hepatologist at the Royal and Liverpool CCG secondary care advisor. Dr Richardson will work closely with Dr Lynn Owens, nurse consultant, at the Royal to deliver the project. The project will be undertaken with input from Dr Fiona Ogden-Forde, Clinical Lead for Alcohol at Liverpool Clinical Commissioning Group. 2Bio Ltd’s Impact Science Team, which provides innovation services to the Royal Liverpool University Hospital, has supported the development of this project from a very early stage.

Dr Richardson, consultant hepatologist at the Royal said, “We are delighted to have secured this award, as it will provide the resource and awareness we need to implement this idea. If successful this project will have a major impact upon the quality of life for patients and their carers, through earlier identification and better understanding of their condition.

“We are looking forward to working with the multidisciplinary team that we have assembled that involves our patients and their families, the nursing team, the clinical commissioning group, psychiatry services, our Service Improvement & Excellence Team, data analysis expertise from our Business Intelligence Team and support from our Innovation Support Team provided by 2Bio Ltd.”

Dr Charley Ward, Senior Business Consultant at 2Bio and the Impact Science Team lead said, “This is a very challenging condition to understand and manage and so we are delighted that the clinical need has been recognised and this award has been made. We’re looking forward to getting started on the project to improve the care of these vulnerable patients.”

Sarah Henderson, Associate Director from the Health Foundation said, “We are very excited to be working with such a high-calibre of teams, who all have great innovative ideas. As an organisation we are keen to support innovation at the frontline across all sectors of health and care services, and I am pleased that we will be able to support these ambitious teams to develop and test their ideas over the next year.

“Our aim is to promote the effectiveness and impact of the teams’ innovations and show how they have succeeded in improving the quality of health care, with the intention of these being widely adopted across the UK.”

The programme will run for fifteen months and each project will receive up to £75,000 of funding to support the implementation and evaluation of the project.

-ENDS-

Contact at the Health Foundation:

Navdeep Sidhu, Marketing and Communications Manager.

T: 020 7257 8067

E: navdeep.sidhu@health.org.uk

  

Notes to editors:

 

About the Health Foundation

The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK.

Our aim is a healthier population, supported by high quality health care that can be equitably accessed. We learn what works to make people’s lives healthier and improve the health care system. From giving grants to those working at the front line to carrying out research and policy analysis, we shine a light on how to make successful change happen.

We make links between the knowledge we gain from working with those delivering health and health care and our research and analysis. Our aspiration is to create a virtuous circle, using what we know works on the ground to inform effective policymaking and vice versa.

We believe good health and health care are key to a flourishing society. Through sharing what we learn, collaborating with others and building people’s skills and knowledge, we aim to make a difference and contribute to a healthier population.  www.health.org.uk

 

About The Royal Liverpool & Broadgreen University Hospitals NHS Trust

The Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England, with an annual budget exceeding £470 million. It delivers services across two sites and three hospitals, the Royal Liverpool University Hospital, Broadgreen Hospital and Liverpool University Dental Hospital, and employs more than 5,500 people. It is one of the top teaching trusts in the UK and is building a brand-new Royal Liverpool University Hospital, which is due to open in 2017. To find out more about the Trust, visit http://www.rlbuht.nhs.uk or follow us on Twitter: @RoyalLpoolHosps or Facebook: www.facebook.com/royalliverpoolhospitals

About 2Bio Limited and the Impact Science Team

2Bio Limited is a UK-based company that provides commercial services, including innovation and IP support, which is delivered through its Impact Science Team. In the UK healthcare sector, 2Bio works predominantly with NHS Trusts and has been providing regular innovation support services to the Royal since 2011 and in 2015 was commissioned by the North West Coast AHSN to create the NHS Innovation Toolkit, which is intended to broaden access to IP and innovation support for smaller or less research-intensive NHS trusts. 2Bio also works with a diverse portfolio of research-related IP and innovations, originating from our UK and international clients, and provides ‘hands on’ support for new business creation in the Life Sciences and Healthcare Industry sectors. Further information can be found at www.impactscience.co.uk or follow us on twitter @impact_science

 

Impact Science Supports Big Data License Deal

aas_story_image

We are pleased to report that one of our clients, Archive Analytics Solutions Ltd., recently completed a significant license deal for its lead product, Indigo, with the University of Maryland. Indigo is a large-scale data repository management system and is being used to support long-term preservation and access to large sets of data, as well as a platform to support research and teaching at The University of Maryland.

Professor Richard Marciano, Director of the Digital Curation and Innovation Center at the University of Maryland, said, “I am delighted that we have secured the Indigo product for our use. We have been been at the heart of the Big Data community, and in particular the effective storage, management and retrieval of data, for many years. Indigo provides us with a number of key advances. We see it as a credible solution for Big Data management in large organisations across many sectors of business and research.”

John Burns, Chief Technology Officer at Archive Analytics Solutions Ltd. said, “We have been working closely with Richard and his team on enhancing the utility of Indigo for some time now, and this agreement provides the next logical step in the evolution of our product. With Richard and his team building on Indigo, we see an exciting future for the product.”

Geoff Wainwright, who led 2Bio’s Impact Science team, said “I’m pleased that we were able to help Archive Analytics and UMD complete this deal, which is a major milestone for Indigo.”

For further information please Contact:

John Burns, Chief Technology Officer, Archive Analytics Solutions Ltd., info@archiveanalytics.com

Prof. Richard Marciano, Digital Curation and Innovation Center, University of Maryland, marciano@umd.edu

Dr. Geoff Wainwright, director 2bio Ltd., info@2bio.co.uk

2Bio’s Impact Science Team chosen for IP support by St. Helens & Knowsley Teaching Hospitals NHS Trust

19th of July, 2016. 2Bio Ltd. and St Helens & Knowsley Teaching Hospitals NHS Trust ( STHK) have announced a partnership agreement for the management and commercialisation of STHK’s intellectual property (IP).

The partnership will encompass all aspects of IP within STHK, beginning with recognising useful ideas and taking them through development, protection and into commercial deals. 2Bio’s Impact Science Team will work closely with the Trust’s staff to build up a portfolio of IP projects and develop them into valuable assets.

Jeanette Anders, STHK’s manager in charge of the Research Development & Innovation Department, said “we’re an innovative NHS Trust and we know that this ultimately benefits our patients and partners; good examples are our early adoption of paperless records and the popular Mersey Micro App – which helps in prescribing antibiotics. This partnership will help us to generate even more benefit from our own IP.”

Dr. Charley Ward leads 2Bio’s Impact Science Team; “we are excited to be working with STHK”, she said “we know that the NHS if full of talented and creative people who have to solve problems on a daily basis, and their solutions can often be useful to other departments, hospitals or other national health systems – we will be helping STHK to bring out the best of this talent and share it with the world”.

2Bio Ltd. has now established a strong client base in the North West of England, including the Walton Centre, the Liverpool Women’s Hospital and the Royal Liverpool & Broadgreen University Hospitals NHS Trust, where the Impact Science Team recently secured a technology deal that will see RLBUHT’s homegrown Patient Flow technology being made commercially available by Sunquest Information Systems, a major international healthcare company. 2Bio’s co-founder and director, Dr. Rhys Roberts, said “we’re looking forward to working with Jeanette and the staff at STHK and helping them to find an appreciative audience for their great ideas and inventions”.

St Helens and Knowsley Teaching Hospitals NHS Trust provides a full range of acute healthcare services at Whiston and St Helens hospitals, including inpatient, outpatient, maternity and emergency service, it also has an active programme of research studies including clinical trials.The Mersey Regional Burns and Plastic Surgery Unit is also located at Whiston Hospital, providing treatment for over 4 million people across the North West of England, North Wales and the Isle of Man. The workforce of over 7,000 staff are dedicated to providing the best possible care, guided by the Trust’s vision to provide ‘5 star patient care’.

Whiston2

2Bio’s Impact Science Team completes technology deal for major UK NHS hospital #innovation #patientflow #IP #techtransfer

RLBUHT’s Electronic Patient Flow Management technology to be commercialised by Sunquest Information Systems.

IMG_7059_wpress

June 14th, 2016. The Royal Liverpool and Broadgreen University Hospitals NHS Trust (the ‘Royal’) has today announced a groundbreaking agreement with Sunquest Information Systems (Europe) Ltd., to commercialise the Royal’s innovative electronic patient flow management system.

Under the agreement, Sunquest will market the solution as a value-add module with their ICE platform, which currently provides electronic ordering and results reporting for almost 50% of NHS Acute Trusts. The application was developed by members of Royal’s Information Management and Technology group, with input from Royal clinicians.

The digital whiteboard and patient flow management solution utilizes software and technology like touch-screen monitors to enable ‘real-time’ tracking of patient admissions, discharges and transfers, operations currently managed through the use of traditional whiteboards on the wards. The digital whiteboard allows ward staff to quickly and easily locate and track a patient’s whereabouts in the hospital, whilst seeing the real time status of relevant key clinical indicators including bedside observations and an early warning system. Overall bed information can be viewed via the solution’s dashboard. This brings together a holistic organisational view of wards, specialties and patients throughout the hospital and allows staff to view a wealth of information. These applications are compatible with Sunquest’s Integrated Clinical Environment (ICE) platform, making important clinical information even more accessible to staff that need it. The digital whiteboard was invented and developed by Tony Morley, Andrew Davies, Steve Manley and Matthew O’Grady Marshall from the IM&T Directorate at the Royal; it’s now a very popular tool in day-to-day use by the organisation.

Speaking about the benefits of the solution, Dr. Holly Metcalf a consultant in acute medicine at the Royal said “Since its implementation the management of the medical intake has significantly improved.  The application provides us with a list of medically referred patients – with important information such as their current location, diagnosis, NEWS (National Early Warning Score), and time of referral. This allows us to prioritise sicker patients, and ensure all of our referrals are seen and treated in a timely manner, ultimately optimising the safety of our patients”.

Jeanette Roberts, lead for the Royal’s Patient Flow Services, said “Since the introduction of electronic bed requests, we have seen smoother transition from admission to transfer and a clear timeline of the patient’s journey to allow further analysis and improvement in service delivery”.

Commenting on this agreement, Aidan Kehoe, the Royal’s Chief Executive said: “This is an important landmark for the Trust’s innovation programme, being the first major commercialisation deal to be concluded on our own technology. This agreement also marks the start of what we expect to be a valuable industry partnership – since we will continue to work with Sunquest to enhance the module as they roll it out to other clinics and hospitals in the UK and internationally.”

“This acquisition represents a fantastic opportunity for both Sunquest and our clients,” said Matt Hawkins, president of Sunquest Information Systems. “The addition of this proven solution will really help to simplify finding beds for patents admitted from A&E, deliver an accurate real time view of patient and bed status across the organisation. As a consequence this will reduce delayed discharges and significantly improve patient care escalations by quickly identifying those patients at most risk, for example with AKI, using the patient observations package.”

Jules West, the Operational Director for Research Development & Innovation (RD&I) at the Royal said: “the need for innovation has never been greater in the NHS and the Royal has taken a proactive approach to its encouragement and application, creating a robust framework for delivering support and monitoring this important activity through our RD&I Directorate; we’ve been supported in this by the Impact Science Team from 2Bio Limited. It is very gratifying to see that the value of this tool, which was developed within our trust, has now been recognised by a leading international company in the healthcare sector. This agreement will not only provide income for us, but should also ensure that this important tool can now be made available to other NHS trusts.”

The Royal’s innovation partner, 2Bio Ltd., delivered the commercialisation support for this technology. Rhys Roberts, the company’s co-founder and director commented: “Everyone involved with the whiteboard has worked very hard to get to this stage. Our Impact Science Team, which was led by Dr. Charley Ward, worked very closely with Andrew Davies at the Royal and with the Sunquest team to achieve this agreement. Looking to the future, it is very promising – we’re now working with a rich pipeline of innovation, so this should be the first of many more useful tools and commercial deals to come out of the Royal.”

NOTES TO EDITORS

About The Royal Liverpool & Broadgreen University Hospitals NHS Trust

The Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England, with an annual budget exceeding £470 million. It delivers services across two sites and three hospitals, the Royal Liverpool University Hospital, Broadgreen Hospital and Liverpool University Dental Hospital, and employs more than 5,500 people.

In the past year the Trust cared for over 90,000 people in their emergency department, around 95,000 day case and inpatients and over 587,000 outpatient appointments. It is one of the top teaching trusts in the UK with well-established links to the University of Liverpool, Liverpool John Moores University and international institutions. The Trust is building a brand-new Royal Liverpool University Hospital, which is due to open in 2017. To find out more about the Trust, visit http://www.rlbuht.nhs.uk or follow us on Twitter: @RoyalLpoolHosps or Facebook: www.facebook.com/royalliverpoolhospitals

About Sunquest Information Systems

Sunquest Information Systems Inc. provides laboratory information systems to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories across the world optimize financial results, enhance efficiency and improve the quality of patient care. The company’s singular focus on diagnostic innovation has delivered solutions that offer unique support for complex testing, enable community-wide connectivity and can be used at the point-of-care. Headquartered in Tucson, AZ, with offices in the United Kingdom and India, Sunquest is a global leader in healthcare information technology. For more information, visit http://www.sunquestinfo.com.

About 2Bio Limited

2Bio Limited is a UK-based company that provides commercial services, including innovation and IP support, which is delivered through its Impact Science Team. In the healthcare sector, 2Bio works predominantly with NHS Trusts, recording and validating useful innovation, identifying Intellectual Property and creating strategies for its development and commercialisation. The Company has been providing regular innovation support services to the Royal since 2011 and in 2015 was commissioned by the North West Coast AHSN to create the NHS Innovation Toolkit, which is intended to broaden access to IP and innovation support for smaller or less research-intensive NHS trusts. 2Bio also works with a diverse portfolio of research-related IP and innovations, owned by our UK and international clients, and provides ‘hands on’ support for new business creation in the Life Sciences and Healthcare Industry sectors. Further information can be found at www.impactscience.co.uk or follow on twitter @impact_science .

ENDS

The Royal Liverpool & Broadgreen University Hospitals NHS Trust wins innovation award to improve quality of health care

A team from The Royal Liverpool & Broadgreen University Hospitals NHS Trust (RLBUHT) has been selected by the Health Foundation, an independent health care charity, to be part of its £1.5 million innovation programme, Innovating for Improvement.

The third round of the Innovating for Improvement programme is supporting twenty health care projects in the UK with the aim of improving health care delivery and/or the way people manage their own health care by testing and developing innovative ideas and approaches and putting them into practice.

The initiative from the Dialysis Unit at The Royal Liverpool & Broadgreen University Hospitals NHS Trust aims to implement a new nurse-led approach to providing improved, personalised, coordinated, multi-disciplinary care in new haemodialysis patients. Commencing haemodialysis is a time of significant risk, and patients experience high levels of physical and psychological distress. This project will involve testing a new nurse-led pathway that will provide patients with better coordinated, personalised treatment plans, with the overall aim of improving the patient experience and of reducing the mortality rate of patients starting haemodialysis.

Over the course of the programme the team will develop its innovative idea and approach, put it into practice and gather evidence about how the innovation improves the quality of health care.

The team will be led by Dr Asheesh Sharma, who will work closely with Sister Vicky Ashworth to deliver the project. 2Bio Ltd’s Impact Science Team provides innovation services to RLBUHT and has supported the development of this project from a very early stage.

Dr Sharma, Consultant Nephrologist and Innovation Lead, RLBUHT said, “ Having recognised the potential to improve the quality of care for this vulnerable group of patients, we are really pleased to have secured this award and now look forward to implementing our ideas. We have pulled together a strong team to deliver this project that involves our nursing team, the clinicians, our patients, our Service Improvement & Excellence Team, data analysis expertise from our Business Intelligence Team and support from our Innovation Support Team provided by 2Bio Ltd. We can’t wait to start making a difference for our patients.”

Dr Charley Ward, Senior Business Consultant at 2Bio said, “We are delighted that this award has been made, it is a great outcome for all the hard work the team has put in so far. We’re looking forward to getting on with the task to make sure that patients at RLBUHT and nationally will benefit from this important innovation in dialysis care.”

Sarah Henderson, Associate Director from the Health Foundation said, “We are very excited to be working with such a high-calibre of teams, who all have great innovative ideas. As an organisation we are keen to support innovation at the frontline across all sectors of health and care services, and I am pleased that we will be able to support these ambitious teams to develop and test their ideas over the next year. “Our aim is to promote the effectiveness and impact of the teams’ innovations and show how they have succeeded in improving the quality of healthcare, with the intention of these being widely adopted across the UK.”

The programme will run for fifteen months and each project will receive up to £75,000 of funding to support the implementation and evaluation of the project.

-ENDS-

Contact at the Health Foundation:

Navdeep Sidhu, Marketing and Communications Manager T: 020 7257 8067 E: navdeep.sidhu@health.org.uk

Mike Findlay, Media Manager T: 0207 257 E: Mike.findlay@health.org.uk

Notes to editors: About the Health Foundation The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK.

Our aim is a healthier population, supported by high quality health care that can be equitably accessed. We learn what works to make people’s lives healthier and improve the health care system. From giving grants to those working at the front line to carrying out research and policy analysis, we shine a light on how to make successful change happen.

We make links between the knowledge we gain from working with those delivering health and health care and our research and analysis. Our aspiration is to create a virtuous circle, using what we know works on the ground to inform effective policymaking and vice versa. We believe good health and health care are key to a flourishing society. Through sharing what we learn, collaborating with others and building people’s skills and knowledge, we aim to make a difference and contribute to a healthier population.

www.health.org.uk